Join
Live feed
·
INSIDERFilingvia Quantisnow
Neurocrine Biosciences Inc. logo

Director Gorman Kevin Charles exercised 205,088 shares at a strike of $43.24 and sold $37,824,872 worth of shares (245,088 units at $154.33) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 511,293 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NBIX (Neurocrine Biosciences Inc.) and more on Quantisnow.

Director Gorman Kevin Charles exercised 205,088 shares at a strike of $43.24 and sold $37,824,872 worth of shares (245,088 units at $154.33) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 511,293 units (SEC Form 4) | Quantisnow